BioNexus Gene Lab Corp. Stock Analysis & AI Score
BioNexus Gene Lab Corp. (BGLC) has an ST Score of 33.2 (C-), driven by its Valuation (A-) and held back by its Growth (F). BGLC last traded at $1.48.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Industrials |
| Industry | Industrial - Distribution |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
BioNexus Gene Lab Corp. (BGLC) has an ST Score of 33.2 (C-), driven by its Valuation (A-) and held back by its Growth (F). BGLC last traded at $1.48.
- Strongest
- ValuationA-
- Weakest
- GrowthF
All factor grades
- ValuationA-
- Financial StrengthA-
- MomentumD-
- ProfitabilityF
- GrowthF
- Piotroski3/9
Contact
BGLC stock: frequently asked questions
What is BGLC's ST Score?
BioNexus Gene Lab Corp. (BGLC) has an ST Score of 33.2 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BGLC a buy, hold, or sell?
Our ST Score grades it C- (33.2/100). The ST Score is a data-driven signal, not a recommendation.
What are BGLC's factor grades?
Valuation A-, Profitability F, Financial Strength A-, Momentum D-, Growth F.
What is BGLC's valuation grade?
BioNexus Gene Lab Corp. (BGLC) earns a valuation grade of A-, measured against Industrial - Distribution peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BGLC's growth grade?
BioNexus Gene Lab Corp. (BGLC) earns a growth grade of F, measured against Industrial - Distribution peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BGLC's profitability grade?
BioNexus Gene Lab Corp. (BGLC) earns a profitability grade of F, measured against Industrial - Distribution peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BGLC's financial strength grade?
BioNexus Gene Lab Corp. (BGLC) earns a financial strength grade of A-, measured against Industrial - Distribution peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is BGLC's Piotroski score?
BioNexus Gene Lab Corp. (BGLC) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.